4169.TW TCM Biotech International Corp.

Healthcare Biotechnology Taiwan Stock Exchange
114.50 TWD
Close of Nov 7, 2026
113.00 290.00
Market cap
TWD 7.57B
P/E
-
P/B
3.87x
ROE
-3.6%
Dividend yield
0.27%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 4169.TW undervalued?

Graham number

The Graham number of TCM Biotech International Corp. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

TCM Biotech International Corp. fundamental analysis

No fundamental analysis for TCM Biotech International Corp. yet.

TCM Biotech International Corp. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About TCM Biotech International Corp.

TCM Biotech International Corp., a biotech company, engages in the research and development of drugs for liver diseases. The company offers medical devices, such as therapy for osteoarthritis, intra-articular implant of hyaluronic acid, automated blood cell separator, absorbable adhesion barrier material, prosthetic and orthotic accessory, and pellefeel mask pressure relief pad; and pharmaceuticals, including iron supplement, therapeutic agent for urinary system, expectorant…

Full company profile